460 results
Page 14 of 23
8-K
EX-99.3
9hwxpn43 vi
24 Feb 11
Dynavax Reports New Phase 1A and Phase 1B Data for Universal Flu Vaccine Candidate
12:00am
8-K
EX-99.1
i0hcdkn
10 Jan 11
Dynavax Completes Enrollment for Phase 3 Study of Heplisav(tm) In Subjects with Chronic Kidney Disease
12:00am
8-K
EX-10.58
ebvxd lwnf87mz
23 Nov 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.59
g0owso
23 Nov 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.57
lv10c20 rb8qciednu
28 Oct 10
Dynavax Announces Proposed Public Offering of Common Stock
12:00am
424B5
p4ndamz
28 Oct 10
Prospectus supplement for primary offering
12:00am
424B5
n5tlk vtfyw
27 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
EX-10.56
m7swmo
13 Oct 10
Entry into a Material Definitive Agreement
12:00am
424B3
acnogh2s6 6dv4rtg3gh
6 Oct 10
Prospectus supplement
12:00am
8-K
EX-99.1
ghi59bu2acc1lpdx1mlw
28 Sep 10
Other Events
12:00am
8-K
EX-10.53
x0vob3bd qs
20 Sep 10
Dynavax Announces $30 Million At-The-Market Common Stock Purchase Agreement
12:00am